CDER RELEASES 2006 GUIDANCE AGENDA

The FDA's Center for Drug Evaluation and Research has released a list of guidance documents it is planning to develop during the 2006 calendar year.

The guidances fall under the following categories: advertising, chemistry, clinical/medical, clinical/pharmacology, combination products, compliance, drug-safety information, electronic submissions, good review practices, investigational new drugs, labeling, OTC, pharmacology/toxicology and procedural.

To view the list, access http://www.fda.gov/cder/guidance/CY06.pdf (http://www.fda.gov/cder/guidance/CY06.pdf).